Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.

Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B.

Hum Pathol. 2010 Aug;41(8):1150-8. doi: 10.1016/j.humpath.2009.11.016. Epub 2010 Apr 8.

PMID:
20381113
2.

Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.

Akar Özkan E, Özdemir BH, Yılmaz Akçay E, Terzi A, Karakuş S, Haberal M.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:183-7.

PMID:
25894151
3.
4.

CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.

Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.

J Clin Oncol. 2007 Nov 1;25(31):4902-8.

PMID:
17971586
5.

Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.

Chen W, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Weiss LM, Wang J.

Am J Clin Pathol. 2009 May;131(5):632-9. doi: 10.1309/AJCP2T4IIIZKBHMI.

PMID:
19369621
6.

Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience.

Cho MC, Park CJ, Huh J, Chi HS, Jang S, Suh C, Lee KH, Lee JH, Seo JJ, Im HJ.

Clin Transplant. 2012 Jul-Aug;26(4):E381-7. doi: 10.1111/j.1399-0012.2012.01667.x. Epub 2012 Jun 13.

PMID:
22694766
7.

Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.

Hanson MN, Morrison VA, Peterson BA, Stieglbauer KT, Kubic VL, McCormick SR, McGlennen RC, Manivel JC, Brunning RD, Litz CE.

Blood. 1996 Nov 1;88(9):3626-33.

8.

Posttransplant lymphoproliferative disorder after liver and kidney transplant.

Akar Özkan E, Özdemir BH, Deniz EE, Tunca MZ, Haberal M.

Exp Clin Transplant. 2014 Mar;12 Suppl 1:142-8.

9.

Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.

Pitman SD, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Berdeja JG, Weiss LM, Wang J.

Am J Surg Pathol. 2006 Apr;30(4):470-6.

PMID:
16625093
10.

Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease.

Hodges GF, Lenhardt TM, Cotelingam JD.

Am J Clin Pathol. 1994 Mar;101(3):305-11.

PMID:
8135186
11.

Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?

Ranganathan S, Webber S, Ahuja S, Jaffe R.

Pediatr Dev Pathol. 2004 Jul-Aug;7(4):348-60. Epub 2004 Jun 17.

PMID:
14564542
12.

Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.

Krishnamurthy S, Hassan A, Frater JL, Paessler ME, Kreisel FH.

Int J Surg Pathol. 2010 Aug;18(4):278-85. doi: 10.1177/1066896909338597. Epub 2009 Jul 3. Erratum in: Int J Surg Pathol. 2010 Oct;18(5):444.

PMID:
19578050
13.

Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

Benkerrou M, Jais JP, Leblond V, Durandy A, Sutton L, Bordigoni P, Garnier JL, Le Bidois J, Le Deist F, Blanche S, Fischer A.

Blood. 1998 Nov 1;92(9):3137-47.

14.

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors.

Dierickx D, Tousseyn T, Sagaert X, Fieuws S, Wlodarska I, Morscio J, Brepoels L, Kuypers D, Vanhaecke J, Nevens F, Verleden G, Van Damme-Lombaerts R, Renard M, Pirenne J, De Wolf-Peeters C, Verhoef G.

Leuk Lymphoma. 2013 Nov;54(11):2433-40. doi: 10.3109/10428194.2013.780655. Epub 2013 Apr 9.

PMID:
23442063
15.

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.

Zimmermann H, Oschlies I, Fink S, Pott C, Neumayer HH, Lehmkuhl H, Hauser IA, Dreyling M, Kneba M, Gärtner B, Anagnostopoulos I, Riess H, Klapper W, Trappe RU.

Transplantation. 2012 Mar 15;93(5):543-50. doi: 10.1097/TP.0b013e318242162d.

PMID:
22234349
16.

Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.

Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.

Am J Surg Pathol. 2006 Mar;30(3):328-36.

PMID:
16538052
17.

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.

Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA.

Cancer. 2005 Oct 15;104(8):1661-7. Review.

18.

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.

Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, Brière J, Blanc M, Gaulard P, Biron P, Schlaifer D, Diebold J, Audouin J.

Am J Surg Pathol. 1996 Jul;20(7):877-88.

PMID:
8669537
19.

Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.

Harris NL, Ferry JA, Swerdlow SH.

Semin Diagn Pathol. 1997 Feb;14(1):8-14.

PMID:
9044505
20.

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.

Johnson LR, Nalesnik MA, Swerdlow SH.

Am J Surg Pathol. 2006 Dec;30(12):1604-12.

PMID:
17122518

Supplemental Content

Support Center